Typhoid Vi polysaccharide conjugate vaccine (Walvax biotechnology)

伤寒Vi多糖结合疫苗（沃森生物）

Report date: 2025/03/26 20:01:25

Base Information

Drug NameTyphoid Vi polysaccharide conjugate vaccine (Walvax biotechnology)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsSalmonella Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusN/A

Highest Status in ChinaN/A

Originator CompaniesWalvax Biotechnology Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A

Inactive CompaniesWalvax Biotechnology Co Ltd

Active IndicationsN/A

Inactive IndicationsSalmonella Infections

Other Information

ATC CodeN/A